You need additional interventions
None of the approved GLP-1 or dual-agonist products carries a dermatologic indication, and the largest relevant real-world study, a target trial emulation with matched cohorts of 169,630 each, found no significant differences for inflammatory or autoimmune skin outcomes other than psoriasis, pemphigus and bullous pemphigoid after correction for multiple testing
Dosage Protocols Generally, initial doses are small
Generally, it involves: Washing your hands
Exenatide has demonstrated the ability to headache frequency [19], however its role in headache in raised ICP is yet to be fully determined headaches severity were similar in both trial arms [19]
These findings underscore the need for a more holistic and long-term approach to weight management, and increased emphasis on the importance of primary prevention of weight gain